Skip to content
★ Sign in to follow
NZ

Niu Zhanqi

Grand Pharmaceutical Group Ltd.
Total declarations
3
Company
1
▲ Purchases (3 ops.)
€85k
▼ Sales (0 ops.)
—

Latest filing published 08 Jun 2022 for Grand Pharmaceutical Group Ltd., €15k.

Filing timeline

BuySale
Niu Zhanqi

Insider track record

Disclosed buys
3
Disclosed sells
0
Signal history

Closed purchases

Market purchases
3
Positive at T+90
100%
Median T+90
+1.2%

Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Niu Zhanqi: trading record in brief

Niu Zhanqi is a declared insider of Grand Pharmaceutical Group Ltd., with filings sourced from HKEX. Over a trading history stretching from 2 June 2022 to 7 June 2022, the count stands at 3 filings.

The open-market record is one-sided, with 3 purchases worth €85k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.

In size, the median ticket on the buying side is €15k. None of the 3 purchases we analysed coincided with buying by another insider of the same company within 30 days. Ninety days after publication, 3 purchases show a median change of +1.2%, with the price up in 100% of them. They describe history only and say nothing certain about the share price ahead.

On 8 June 2022 came the latest disclosure, an open-market purchase for €15k in Grand Pharmaceutical Group Ltd. Filings reach the HKEX feed a median of 2 days after the trade. The shorter that gap, the sooner other investors can see what insiders have done. Every figure here comes from the filings published by HKEX and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Niu Zhanqi

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations3 total

3 of 3 declarations